Caterina Ivaldo

Genoa, 16132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Heme Oxygenase-1 Contributes to Dampening Proinflammatory Activation in the Human Microglial Cell Line HMC3 and Controls the Transcription Factor IRF5.

Heme Oxygenase-1 Contributes to Dampening Proinflammatory Activation in the Human Microglial Cell Line HMC3 and Controls the Transcription Factor IRF5.

Journal: Biomolecules

Published: March 03, 2026

Repeated aluminum ingestion alters human intestinal structure: focus on advanced 3D tissue models.

Repeated aluminum ingestion alters human intestinal structure: focus on advanced 3D tissue models.

Journal: Pflugers Archiv : European journal of physiology

Published: February 03, 2026

L19-Conjugated Gold Nanoparticles for the Specific Targeting of EDB-Containing Fibronectin in Neuroblastoma.

L19-Conjugated Gold Nanoparticles for the Specific Targeting of EDB-Containing Fibronectin in Neuroblastoma.

Journal: Pharmaceutics

Published: November 26, 2025

An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice.

An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Artery tertiary lymphoid organs, neuro-immune interaction and their mediators in atherosclerosis.

Artery tertiary lymphoid organs, neuro-immune interaction and their mediators in atherosclerosis.

Journal: Basic research in cardiology

Published: October 22, 2025

An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice.

An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice.

Journal: Blood vessels, thrombosis & hemostasis

Published: October 17, 2025

A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model.

A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model.

Journal: International journal of molecular sciences

Published: June 24, 2025

AhR, IRF5, and HO-1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study.

AhR, IRF5, and HO-1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study.

Journal: Journal of the American Heart Association

Published: May 15, 2025

The Genoa Vascular Biobank: A Today Resource for Future Perspectives in Vascular Research.

The Genoa Vascular Biobank: A Today Resource for Future Perspectives in Vascular Research.

Journal: Biomarker insights

Published: October 28, 2024

HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia.

HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia.

Journal: Antioxidants (Basel, Switzerland)

Published: May 17, 2022

Oxidative stress-induced MMP- and γ-secretase-dependent VE-cadherin processing is modulated by the proteasome and BMP9/10.

Oxidative stress-induced MMP- and γ-secretase-dependent VE-cadherin processing is modulated by the proteasome and BMP9/10.

Journal: Scientific reports

Published: December 31, 2021

Clinical Significance of Heme Oxygenase 1 in Tumor Progression.

Clinical Significance of Heme Oxygenase 1 in Tumor Progression.

Journal: Antioxidants (Basel, Switzerland)

Published: March 30, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026